|
|
|
|
| Symbol(s): |
RVX.TO |
| Date: |
7-Mar-13 |
| Author: |
George Zavoico |
| Contributor: |
Streetwise Reports |
| Title: |
Resverlogix Corp.: Phase 2b ASSURE Trial Could Be a Major Victory |
| Document Size: |
2 pages |
| Price: |
$11.50 |
| Document Type: |
Adobe Acrobat Reader®
Download free Adobe Acrobat Reader® |
|
| Research Reports Premium Services |
| ·
|
Get the full report for $11.50. |
| ·
|
You will have access to this report for 24 hours. |
|
|
|
| Preview: |
|
|
|
|
|
| The following is an excerpt from the Streetwise Reports interview with George Zavoico, Senior Analyst and Managing Director of MLV & Co., "10 Biotech Stocks Poised to Run."
| | |
|
|